Christopher Pierce
Plus aucun poste en cours
Historique de carrière de Christopher Pierce
Anciens postes connus de Christopher Pierce
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01/07/2020 | 30/09/2021 |
| Scout Advisers LLC | Corporate Officer/Principal | 01/08/2019 | 01/07/2020 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/04/2017 | 01/05/2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01/07/2016 | 01/03/2017 |
Formation de Christopher Pierce
| Harvard College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Scout Advisers LLC | |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bourse
- Insiders
- Christopher Pierce
- Expérience
